Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Times Interest Earned (2024 - 2026)

Kura Oncology has reported Times Interest Earned over the past 3 years, most recently at -$234.57 for Q1 2026.

  • Quarterly Times Interest Earned fell 38.49% to -$234.57 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$13.97 through Mar 2026, up 87.95% year-over-year, with the annual reading at -$200.81 for FY2025, 68.28% down from the prior year.
  • Times Interest Earned was -$234.57 for Q1 2026 at Kura Oncology, down from $571.64 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $571.64 in Q4 2025 and troughed at -$234.57 in Q1 2026.
  • The 3-year median for Times Interest Earned is -$131.05 (2024), against an average of -$67.6.
  • The largest YoY upside for Times Interest Earned was 1471.58% in 2025 against a maximum downside of 43.15% in 2025.
  • A 3-year view of Times Interest Earned shows it stood at -$41.68 in 2024, then soared by 1471.58% to $571.64 in 2025, then tumbled by 141.03% to -$234.57 in 2026.
  • Per Business Quant, the three most recent readings for KURA's Times Interest Earned are -$234.57 (Q1 2026), $571.64 (Q4 2025), and -$187.59 (Q3 2025).